cytojene corporation
Beckman Coulter Acquires China’s Xitogen
Beckman Coulter’s acquisition of Xitogen is expected to enhance its presence in Asia and enable it to respond to customers in the region.
Beckman Coulter’s acquisition of Xitogen is expected to enhance its presence in Asia and enable it to respond to customers in the region.
